With An Import Alert, India's Aurobindo Reels Under U.S. FDA Glare; Four Pfizer Products Impacted

MUMBAI - In what is being described as a body blow to the reputation of Indian drug companies, U.S. FDA imposed an import alert against one manufacturing site of Aurobindo Pharma located near the central Indian city of Hyderabad